MA
51
-2
VRSK
25
-3
MMM
54
-3
EQR
39
-3
RSG
50
-4
FLS
50
-5
BRK.B
43
-6
BLK
57
-3
SIG
52
5
PCG
67
-2
ALL
60
-3
ORCL
28
3
HIG
60
-3
AIG
74
-4
COF
67
2
ILMN
68
-2
PEG
53
-2
AAP
5
-3
MDT
53
-2
PHM
55
-3
MA
51
-2
VRSK
25
-3
MMM
54
-3
EQR
39
-3
RSG
50
-4
FLS
50
-5
BRK.B
43
-6
BLK
57
-3
SIG
52
5
PCG
67
-2
ALL
60
-3
ORCL
28
3
HIG
60
-3
AIG
74
-4
COF
67
2
ILMN
68
-2
PEG
53
-2
AAP
5
-3
MDT
53
-2
PHM
55
-3
Financhill
Back

Parametric Equity Premium Income ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
61

PAPI
Parametric Equity Premium Income ETF

Last Price:
$26.23
Seasonality Move:
4.07%
Sell
36

MNPR
Monopar Therapeutics, Inc.

Last Price:
$71.77
Seasonality Move:
36.18%
Buy
61
Parametric Equity Premium Income ETF (PAPI) is a Buy

Is Parametric Equity Premium Income ETF a Buy, Sell or Hold?

  • The current Parametric Equity Premium Income ETF [PAPI] share price is $26.06. The Score for PAPI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • PAPI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PAPI Stock Price Chart

What is Parametric Equity Premium Income ETF's stock price today?

  • The Parametric Equity Premium Income ETF share price today is $26.06
    The current trend is moderately bullish and PAPI is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $71.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

PAPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 53.64 Buy
Chaikin Money Flow: -26163 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.27 Sell
Relative Strength Index (14 RSI): 37.77 Sell
Chaikin Money Flow: -61015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

PAPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.11 Sell
20-day SMA: 25.91 Buy
50-day SMA: 25.77 Buy
200-day SMA: 25.73 Buy
8-day EMA: 26.13 Sell
20-day EMA: 25.98 Buy
50-day EMA: 25.35 Buy
200-day EMA: 16.14 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.09 Sell
20-day SMA: 80.86 Sell
50-day SMA: 83.38 Sell
200-day SMA: 51.78 Buy
8-day EMA: 75.84 Sell
20-day EMA: 78.85 Sell
50-day EMA: 77.98 Sell
200-day EMA: 56.35 Buy

Parametric Equity Premium Income ETF Earnings Growth & PAPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Parametric Equity Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):